METACARE will proceed with a $6 billion won paid-in capital increase for its parent company MetaLabs. METACARE plans to use the secured funds to acquire shares of another company to secure growth drivers.
On the 9th, METACARE disclosed that it decided on a third-party allotment paid-in capital increase worth 6 billion won for its largest shareholder, MetaLabs.
The company plans to use the secured funds to acquire shares of another company going forward. Through this, it plans to secure medium- to long-term growth drivers and pursue an expansion of its business portfolio.
After this paid-in capital increase, MetaLabs' equity stake is expected to rise from 37.28% to 51.78%. A METACARE official said, "This paid-in capital increase is a decision in which the largest shareholder directly shows trust in and willingness to support the company's growth potential and business expansion strategy."